Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × plerixafor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 33 Lymphoma, Non-Hodgkin 27 Leukemia, Myeloid, Acute 21 Hodgkin Disease 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Myelodysplastic Syndromes 10 Lymphoma 10 Leukemia, Lymphocytic, Chronic, B-Cell 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Neoplasms, Plasma Cell 4 Leukemia 4 Pancreatic Neoplasms 3 Lymphoma, Mantle-Cell 3 Lymphoma, Follicular 3 Warts 2 Sezary Syndrome 2 Neutropenia 2 Myeloproliferative Disorders 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Hairy Cell 2 Infections 2 Immunologic Deficiency Syndromes 2 Hematologic Neoplasms 2 Gliosarcoma 2 Glioma 2 Glioblastoma 2

Interventions

Doxorubicin 120 Ifosfamide 70 Radiotherapy 65 Cyclophosphamide 61 Gemcitabine 53 Filgrastim 46 Trabectedin 36 pazopanib 34 Docetaxel 34 Etoposide 33 pembrolizumab 32 Vincristine 30 Cisplatin 29 Nivolumab 27 Irinotecan 21 Magnetic Resonance Spectroscopy 20 Carboplatin 20 Ipilimumab 19 Surgical Procedures, Operative 18 Radiation 18 Temozolomide 17 Mesna 16 Melphalan 16 Biopsy 16 Bevacizumab 16 Sirolimus 15 Granulocyte Colony-Stimulating Factor 15 Drug Therapy 15 Dactinomycin 15 Blood Specimen Collection 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03240861 2023-11-01

NYESO SCT

Jonsson Comprehensive Cancer Center

Phase 1 Terminated

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡